Deletion of tumor suppressor genes in Chinese non-small cell lung cancer

被引:28
作者
An, Q
Liu, Y
Gao, YN
Huang, JF
Fong, XL
Liu, LY
Zhang, DC
Zhang, JJ
Cheng, SJ [1 ]
机构
[1] Peking Union Med Coll, Canc Inst Hosp, Dept Chem Etiol & Carcinogenesis, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100021, Peoples R China
[3] Third Mil Med Univ, Prevent Med Coll, Hyg Toxicol Dept, Chongqing 400038, Peoples R China
关键词
loss of heterozygosity; tumor suppressor gene; squamous cell carcinoma; adenocarcinoma; lung cancer;
D O I
10.1016/S0304-3835(02)00204-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, we used 22 microsatellite markers flanking to or within 13 known or candidate tumor suppressor genes (TSGs) to detect loss of heterozygosity (LOH) in these chromosomal regions among 41 cases of non-small cell lung cancer, including 28 squamous cell carcinoma (SCC) and 13 adenocarcinoma (ADC). The studied TSGs comprised FHIT, VHL, APC, PRLTS, p16, IFNA, PTEN, p57, ATM, p53, BRCA1, DPC4 and DCC. Our data demonstrated frequent allelic losses of FHIT, p53, IFNA, VHL and p16 in both SCC and ADC. PTEN and ATM showed the least frequency of LOH, while no deletion of BRCA1 was detected in all tumor samples. LOH analysis of PRLTS was extended to 26 cases of ADC, which demonstrated significantly higher frequency of LOH than SCC. Our data indicated a possible correlation between specific TSG(s) and either histological type of lung cancer, and more attention should be paid to the PRLTS gene, which might play an important role in the development of ADC. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 48 条
[1]   GROWTH-FACTORS AND CANCER [J].
AARONSON, SA .
SCIENCE, 1991, 254 (5035) :1146-1153
[2]   MALIGNANT EPITHELIAL-CELLS IN PRIMARY HUMAN LUNG CARCINOMAS COEXPRESS INVIVO PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND PDGF RECEPTOR MESSENGER-RNAS AND THEIR PROTEIN PRODUCTS [J].
ANTONIADES, HN ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
OHARA, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3942-3946
[3]  
Califano J, 1996, CANCER RES, V56, P2488
[4]  
Cooper CA, 1996, J PATHOL, V180, P33
[5]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
[6]   Mutation analysis of the PTEN/MMAC1 gene in lung cancer [J].
Forgacs, E ;
Biesterveld, EJ ;
Sekido, Y ;
Fong, K ;
Muneer, S ;
Wistuba, II ;
Milchgrub, S ;
Brezinschek, R ;
Virmani, A ;
Gazdar, AF ;
Minna, JD .
ONCOGENE, 1998, 17 (12) :1557-1565
[7]  
FUJIWARA Y, 1995, ONCOGENE, V10, P891
[8]   Mechanisms of p16INK4A inactivation in non small-cell lung cancers [J].
Gazzeri, S ;
Gouyer, V ;
Vourc'h, C ;
Brambilla, C ;
Brambilla, E .
ONCOGENE, 1998, 16 (04) :497-504
[9]   Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features [J].
Geradts, J ;
Fong, KM ;
Zimmerman, PV ;
Minna, JD .
BRITISH JOURNAL OF CANCER, 2000, 82 (06) :1191-1197
[10]  
Girard L, 2000, CANCER RES, V60, P4894